| 101945-4 |
Candida tropicalis DNA |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Candida tropicalis DNA [Presence] in Specimen by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101945-4 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
C tropicls DNA Spec Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C tropicls; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101946-2 |
Candida tropicalis DNA |
PrThr |
Urine |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Candida tropicalis DNA [Presence] in Urine by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101946-2 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
C tropicls DNA Ur Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C tropicls; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101947-0 |
Cytomegalovirus DNA |
PrThr |
Respiratory System Specimen |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Cytomegalovirus DNA [Presence] in Respiratory system specimen by NAA with probe detection |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101947-0 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
CMV DNA Resp Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breathing; CMV; Cytomegalo virus; Cytomgal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HHV-5; Human Herpesvirus-5; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; RS; Screen; SDA; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.77 |
2.75 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: SYSTEM: Updated to the new value Respiratory System Specimen from Respiratory.; |
0 |
| 101948-8 |
Cytomegalovirus DNA |
PrThr |
Stool |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Cytomegalovirus DNA [Presence] in Stool by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101948-8 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
CMV DNA Stl Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; CMV; Cytomegalo virus; Cytomgal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; HHV-5; Human Herpesvirus-5; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101949-6 |
Mycoplasma genitalium hominis DNA |
PrThr |
Wound |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Mycoplasma genitalium+hominis DNA [Presence] in Wound by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101949-6 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
M gen+homDNA Spec Ql NAA+pro |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M genitalium; M genitalium+hominis; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmoides genitalium; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Wnd |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 10195-6 |
Physical findings |
Find |
Ear |
Pt |
Nar |
Observed |
|
ACTIVE |
Physical findings of Ear Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.PX |
|
10195-6 |
|
Observed |
|
|
|
|
|
|
0 |
Phys find Ear |
|
|
|
|
|
Exam; Examination; Finding; Findings; H+P; H+P.PX; Hearing; Narrative; Otologic; P prime; Phys find; Point in time; Random; Report |
2.4 |
1.0i |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101950-4 |
Streptococcus pyogenes DNA |
PrThr |
Wound |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Streptococcus pyogenes DNA [Presence] in Wound by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101950-4 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
S pyo DNA Wnd Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; GAS; Group A Strep; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S pyogenes; Screen; SDA; Steptococcus Group A; Strand Displacement Amplification; Strep; Strept; Streptococci group A; Streptococcus group A; TMA; Transcription mediated amplification; Wnd |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101951-2 |
NIPS Assessment |
Imp |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
NIPS assessment (interpretation) |
|
NAM |
DefinitionDescription |
|
|
|
|
�© 1989, Children's Hospital of Eastern Ontario. Used with permission. |
|
|
|
|
H&P.HX |
|
101951-2 |
|
|
|
|
Observation |
|
|
|
0 |
NIPS inter |
|
|
|
N |
|
H+P; H+P.HX; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen |
2.76 |
2.75 |
|
|
|
|
�© 1989, Children's Hospital of Eastern Ontario. Used with permission. |
|
|
|
|
|
|
0 |
| 101952-0 |
MTTP gene targeted mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
MTTP gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
N/A |
|
|
|
MOLPATH.MUT |
|
101952-0 |
|
Molgen |
|
|
Both |
|
|
|
0 |
MTTP Mut Anl Bld/T |
|
|
|
N |
|
ABL; Blood; Document; Finding; Findings; microsomal triglyceride transfer protein; microsomal triglyceride transfer protein (large polypeptide, 88kD); microsomal triglyceride transfer protein (large polypeptide, 88kDa); Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; MTP; MTTP Mut Anl� ; Mut; Mut Anl; Mutations; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101953-8 |
COL4A3 gene targeted mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
COL4A3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
N/A |
|
|
|
MOLPATH.MUT |
|
101953-8 |
|
Molgen |
|
|
Both |
|
|
|
0 |
COL4A3 gene Mut Anl Bld/T |
|
|
|
N |
|
Blood; COL4A3; COL4A3 Mut Anl; collagen, type IV, alpha 3 (Goodpasture antigen); Document; Finding; Findings; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; PCR; Point in time; Random; Tissue; Tissue, unspecified; tumstatin; WB; Whole blood; Whole blood or Tissue |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101954-6 |
SLC35A3 gene targeted mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
SLC35A3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
N/A |
|
|
|
MOLPATH.MUT |
|
101954-6 |
|
Molgen |
|
|
Both |
|
|
|
0 |
SLC35A3 gene Mut Anl Bld/T |
|
|
|
N |
|
Blood; Document; Finding; Findings; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; PCR; Point in time; Random; SLC35A3; SLC35A3 Mut Anl; solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member 3; solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member A3; Tissue; Tissue, unspecified; Vet; Veterinary; WB; Whole blood; Whole blood or Tissue |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101955-3 |
DNAI1 gene targeted mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
DNAI1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
NAM |
DefinitionDescription |
|
|
|
|
|
N/A |
|
|
|
MOLPATH.MUT |
|
101955-3 |
|
Molgen |
|
|
Both |
|
|
|
0 |
DNAI1 gene Mut Anl Bld/T |
|
|
|
N |
|
Blood; DIC1 PCD CILD1; DNAI Mut Anl; DNAI1; DNAI1 Mut Anl; Document; dynein, axonemal, intermediate polypeptide 1; Finding; Findings; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.77 |
2.75 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: COMPONENT: The older value was wrongly corrected; |
0 |
| 101956-1 |
COQ4 gene targeted mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
COQ4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
N/A |
|
|
|
MOLPATH.MUT |
|
101956-1 |
|
Molgen |
|
|
Both |
|
|
|
0 |
COQ4 gene Mut Anl Bld/T |
|
|
|
N |
|
Blood; coenzyme Q4 homolog (S. cerevisiae); coenzyme Q4 homolog (yeast; COQ4; COQ4 Mut Anl; Document; Finding; Findings; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101957-9 |
RTEL1 gene targeted mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
RTEL1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
N/A |
|
|
|
MOLPATH.MUT |
|
101957-9 |
|
Molgen |
|
|
Both |
|
|
|
0 |
RTEL1 gene Mut Anl Bld/T |
|
|
|
N |
|
Blood; chromosome 20 open reading frame 41; Document; Finding; Findings; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; PCR; Point in time; Random; regulator of telomere elongation helicase 1; RTEL1; RTEL1 Mut Anl; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101958-7 |
ADAMTS2 gene targeted mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
ADAMTS2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
N/A |
|
|
|
MOLPATH.MUT |
|
101958-7 |
|
Molgen |
|
|
Both |
|
|
|
0 |
ADAMTS2 gene Mut Anl Bld/T |
|
|
|
N |
|
ADAMTS2 Mut Anl; Blood; Document; Finding; Findings; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101959-5 |
TCIRG1 gene targeted mutation |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
TCIRG1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
N/A |
|
|
|
MOLPATH.MUT |
|
101959-5 |
|
Molgen |
|
|
Both |
|
|
|
0 |
TCIRG1 Mut Anl Bld/T |
|
|
|
N |
|
Blood; Document; Finding; Findings; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; PCR; Point in time; Random; T cell immune regulator 1, ATPase H+ transporting V0 subunit a3; T-cell immune regulator 1, ATPase H+ transporting V0 subunit a3; T-cell immune response cDNA 7; T-cell, immune regulator 1; T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 protein a isoform 3; T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3; TCIRG1 Mut Anl; Tissue; Tissue, unspecified; V-ATPase subunit a3; WB; Whole blood; Whole blood or Tissue |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 10196-4 |
Physical findings |
Find |
Extremities |
Pt |
Nar |
Observed |
|
ACTIVE |
Physical findings of Extremities Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.PX |
|
10196-4 |
|
Observed |
|
|
|
|
|
|
0 |
Phys find Extremities |
|
|
|
|
|
Exam; Examination; Finding; Findings; H+P; H+P.PX; Limbs; Narrative; P prime; Phys find; Point in time; Random; Report |
2.4 |
1.0i |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101960-3 |
PEX2 gene targeted mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
PEX2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
N/A |
|
|
|
MOLPATH.MUT |
|
101960-3 |
|
Molgen |
|
|
Both |
|
|
|
0 |
PEX2 gene Mut Anl Bld/T |
|
|
|
N |
|
Blood; Document; Finding; Findings; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; PCR; peroxin 2; peroxisomal biogenesis factor 2; peroxisomal membrane protein 3 (35kD, Zellweger syndrome); peroxisomal membrane protein 3, 35kDa; PEX2 Mut Anl; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue; Zellweger syndrome |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101961-1 |
PHGDH gene targeted mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
PHGDH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
N/A |
|
|
|
MOLPATH.MUT |
|
101961-1 |
|
Molgen |
|
|
Both |
|
|
|
0 |
PHGDH gene Mut Anl Bld/T |
|
|
|
N |
|
Blood; Document; Finding; Findings; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; PCR; PHGDH Mut Anl; phosphoglycerate dehydrogenase; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101962-9 |
DHDDS gene targeted mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
DHDDS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
N/A |
|
|
|
MOLPATH.MUT |
|
101962-9 |
|
Molgen |
|
|
Both |
|
|
|
0 |
DHDDS gene Mut Anl Bld/T |
|
|
|
N |
|
Blood; dehydrodolichyl diphosphate synthase; dehydrodolichyl diphosphate synthase subunit; DHDDS Mut Anl; Document; Finding; Findings; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101963-7 |
SLC1A4 gene targeted mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
SLC1A4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
N/A |
|
|
|
MOLPATH.MUT |
|
101963-7 |
|
Molgen |
|
|
Both |
|
|
|
0 |
SLC1A4 gene Mut Anl Bld/T |
|
|
|
N |
|
alanine/serine/cysteine/threonine transporter; Blood; Document; Finding; Findings; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; neutral amino acid transporter A; PCR; Point in time; Random; SLC1A4 Mut Anl; solute carrier family 1 (glutamate/neutral amino acid transporter), member 4; solute carrier family 1 member 4; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101964-5 |
HPS3 gene targeted mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
HPS3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
N/A |
|
|
|
MOLPATH.MUT |
|
101964-5 |
|
Molgen |
|
|
Both |
|
|
|
0 |
HPS3 gene Mut Anl Bld/T |
|
|
|
N |
|
Blood; Document; Finding; Findings; Hermansky-Pudlak syndrome 3; HPS3; HPS3 Mut Anl; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101965-2 |
NDUFAF5 gene targeted mutation |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
NDUFAF5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
N/A |
|
|
|
MOLPATH.MUT |
|
101965-2 |
|
Molgen |
|
|
Both |
|
|
|
0 |
NDUFAF5 Mut Anl Bld/T |
|
|
|
N |
|
Blood; Document; Finding; Findings; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; NDUFAF5 Mut Anl; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101967-8 |
Neonatal infant pain scale panel (NIPS) |
- |
^Patient |
Pt |
- |
NIPS |
|
ACTIVE |
Neonatal infant pain scale panel (NIPS) |
|
MIN |
DefinitionDescription |
|
|
|
|
�© 1989, Children's Hospital of Eastern Ontario. Used with permission. |
|
|
|
|
PANEL.NEONAT |
|
101967-8 |
|
NIPS |
|
|
Order |
|
|
|
0 |
NIPS panel |
|
|
|
N |
|
NIPS panel; Pan; PANEL.NEONAT; Panl; Pnl; Point in time; Random |
2.76 |
2.75 |
|
Panel |
|
|
�© 1989, Children's Hospital of Eastern Ontario. Used with permission. |
|
|
|
|
|
|
0 |
| 101968-6 |
Circulating tumor cells |
NCnc |
Plas/Bld |
Pt |
Qn |
Sequencing |
|
ACTIVE |
Circulating tumor cells [#/volume] in Plasma or Blood by Sequencing |
|
ADD |
DefinitionDescription |
|
|
mol/mL |
|
|
|
|
|
|
CHEM |
|
101968-6 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
Circ Tumor cells # PlasBld Seq |
|
|
|
N |
|
#; ABS; absolute; absolutes; Blood; Cell; Cellularity; Chemistry; Circ; Circ Tumor cells; Circulating cancer cells; Circulating epithelial cells; Cnt; Count; Count/volume; CT; CTC; EpCAM+Ck-PE+PAPI+CD45- cells; high-throughput sequencing; HTS; Next generation sequencing; NGS; Number concentration; Number Concentration (count/vol); Pl; PlasBld; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; TC; WB; Whole blood |
2.75 |
2.75 |
|
|
|
|
|
|
|
mol/mL |
|
|
|
0 |
